Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


pCI-neo beta catenin WT Citations (9)

Originally described in: Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.
Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW Science. 1997 Mar 21. 275(5307):1787-90.
PubMed Journal

Articles Citing pCI-neo beta catenin WT

AMP-activated protein kinase (AMPK) cross-talks with canonical Wnt signaling via phosphorylation of beta-catenin at Ser 552. Zhao J, Yue W, Zhu MJ, Sreejayan N, Du M. Biochem Biophys Res Commun. 2010 Apr 23;395(1):146-51. doi: 10.1016/j.bbrc.2010.03.161. Epub 2010 Mar 31. PubMed
Rough surface topography enhances the activation of Wnt/beta-catenin signaling in mesenchymal cells. Galli C, Passeri G, Ravanetti F, Elezi E, Pedrazzoni M, Macaluso GM. J Biomed Mater Res A. 2010 Dec 1;95(3):682-90. doi: 10.1002/jbm.a.32887. PubMed
Dickkopf 4 (DKK4) acts on Wnt/beta-catenin pathway by influencing beta-catenin in hepatocellular carcinoma. Fatima S, Lee NP, Tsang FH, Kolligs FT, Ng IO, Poon RT, Fan ST, Luk JM. Oncogene. 2012 Sep 20;31(38):4233-44. doi: 10.1038/onc.2011.580. Epub 2012 Jan 16. PubMed
Regulation of the DLG tumor suppressor by beta-catenin. Subbaiah VK, Narayan N, Massimi P, Banks L. Int J Cancer. 2012 Nov 15;131(10):2223-33. doi: 10.1002/ijc.27519. Epub 2012 Mar 28. PubMed
Beta-catenin is involved in Bex2 down-regulation induced glioma cell invasion/migration inhibition. Nie E, Zhang X, Xie S, Shi Q, Hu J, Meng Q, Zhou X, Yu R. Biochem Biophys Res Commun. 2015 Jan 2;456(1):494-9. doi: 10.1016/j.bbrc.2014.11.113. Epub 2014 Dec 6. PubMed
Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by beta-Catenin Mutations. Adebayo Michael AO, Ko S, Tao J, Moghe A, Yang H, Xu M, Russell JO, Pradhan-Sundd T, Liu S, Singh S, Poddar M, Monga JS, Liu P, Oertel M, Ranganathan S, Singhi A, Rebouissou S, Zucman-Rossi J, Ribback S, Calvisi D, Qvartskhava N, Gorg B, Haussinger D, Chen X, Monga SP. Cell Metab. 2019 May 7;29(5):1135-1150.e6. doi: 10.1016/j.cmet.2019.01.002. Epub 2019 Jan 31. PubMed
Targeting beta-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations. Moon JH, Hong SW, Kim JE, Shin JS, Kim JS, Jung SA, Ha SH, Lee S, Kim J, Lee DH, Park YS, Kim DM, Park SS, Hong JK, Kim DY, Kim EH, Jung J, Kim MJ, Kim SM, Deming DA, Kim K, Kim TW, Jin DH. Br J Cancer. 2019 Apr;120(9):941-951. doi: 10.1038/s41416-019-0434-5. Epub 2019 Apr 4. PubMed
Single-domain near-infrared protein provides a scaffold for antigen-dependent fluorescent nanobodies. Oliinyk OS, Baloban M, Clark CL, Carey E, Pletnev S, Nimmerjahn A, Verkhusha VV. Nat Methods. 2022 May 23. pii: 10.1038/s41592-022-01467-6. doi: 10.1038/s41592-022-01467-6. PubMed

Associated Plasmids

Targeting Triple Negative Breast Cancer Stem Cells by Heat Shock Protein 70 Inhibitors. Tsai CH, Weng JR, Lin HW, Lu MT, Liu YC, Chu PC. Cancers (Basel). 2022 Oct 7;14(19):4898. doi: 10.3390/cancers14194898. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.